Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bass, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bass, H.
(Chest. 1972;61:14-17.)
© 1972 American College of Chest Physicians

Endogenous Regulation of the Pulmonary Response to Isoproterenol

Harry Bass M.D., F.C.C.P.1

1 Director, Pulmonary Division and Senior Associate in Medicine, Peter Bent Brigham Hospital; Assistant Professor of Medicine, Harvard Medical School

Pulmonary function was evaluated before and after isoproterenol administration in eight asthmatic patients who had been taking daily suppressive doses of glucocorticosteroids prior to study. Results were compared when the patients were not on glucocorticosteroid therapy, after glucocorticosteroid therapy, and after ACTH stimulation. Before isoproterenol administration, values were significantly closer to normal after ACTH than on no therapy or glucocorticosteroid therapy. Isoproterenol response was of great magnitude when no therapy was given and minimal after glucocorticosteroids or ACTH. Following isoproterenol, values were significantly closer to normal following ACTH compared to glucocorticosteroid therapy, and values on no therapy were intermediate not separating significantly from glucocorticosteroid therapy or ACTH stimulation. ACTH stimulates an increase in adrenal adenyl cyclase, cyclic AMP, and phenylethanolamine-N-methyl transferase with a resultant increase in the conversion of norepinephrine to epinephrine, a potent beta stimulator. The inability of these suppressed patients to release ACTH following discontinuation of glucocorticosteroids led to diminished epinephrine production, diminished endogenous beta stimulation, and maximal response to isoproterenol.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by the American College of Chest Physicians.